BioPharma

02 June, 2026 | Tuesday | Analysis

When America Builds a Wall: Who Inherits China’s Displaced Biotech Work?

When President Trump signed the FY2026 National Defense Authorization Act on December 18, 2025, the biopharmaceutical industry finally got the law it had spent three years anticipating, debating, and quietly he...

Lab

03 June, 2026 | Wednesday | News

Thermo Fisher Scientific Simplifies Nucleic Acid Verification With New E Gel Power Snap Lite System

Thermo Fisher Scientific announced the launch of the Invitrogen™ E-Gel™ Power Snap Lite Electrophoresis System, a compact, all-in-one solution designed for routine nucleic acid verification workflow...

BioTech

02 June, 2026 | Tuesday | Analysis

Innovation Powerhouse or Inflated Bubble? Reading China’s First-in-Class Boom

A decade ago, the phrase “Chinese first-in-class drug” would have drawn a raised eyebrow in any Western boardroom. China made generics, copied mechanisms, and ran cheap trials. The frontier of biolo...

Contract Services

02 June, 2026 | Tuesday | Analysis

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” was online — more than 1,000 NVIDIA Blackwell Ult...

Consumer Health

04 June, 2026 | Thursday | News

NOVI Health and Novo Nordisk Partner to Expand Access to Structured Medical Weight Care in Singapore

The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. NOVI Health announced a strategic partnership with Novo Nordisk ...

Medtech

03 June, 2026 | Wednesday | News

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™:  a High-Throughput ADME Platform That Brings Pharmacokinetic Projection  Earlier in Drug Discovery   New co-d...

Cell & Gene

03 June, 2026 | Wednesday | Analysis

Curative but Unaffordable: Gene and Cell Therapy's Access Paradox in Asia

At almost every cell-and-gene-therapy conference in the region, the same slide appears: a child who was dying of leukaemia, now in durable remission; a teenager freed from a lifetime of blood transfusions; a gr...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close